JAZZ
Jazz Pharmaceuticals PLC
240.60$
-0.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +31.1% | +11.0% | +17.4% | +15.3% | -2.8% | +15.9% | -13.5% | +63.4% | -14.1% | +27.8% | -2.9% | |
| – | -19.2% | +5.3% | +45.2% | +31.2% | +70.8% | -24.8% | +98.6% | +13.9% | +1.5% | +3.3% | +5.5% | |
| – | +31.5% | +7.9% | +8.2% | -4.2% | +7.9% | +9.4% | +56.2% | +17.5% | +2.2% | +9.3% | +17.4% | |
| – | -10.4% | -7.9% | -281.2% | – | -114.1% | – | +288.9% | -77.0% | – | – | – | |
| – | – | – | – | -13.0% | -744.5% | – | – | – | -2,164.0% | – | – | |
| – | -85.0% | +405.0% | -37.2% | +15.4% | +38.7% | +108.0% | -88.0% | +994.2% | -95.2% | +100.6% | +336.3% | |
| – | -99.8% | +77,474.3% | -84.6% | +46.7% | -60.6% | +548.9% | +417.2% | -91.4% | -63.5% | +211.7% | +197.1% | |
| – | – | – | – | – | – | +72.4% | 0.0% | -1.6% | – | – | – | |
| – | +45.8% | +352.1% | -64.5% | +430.0% | -42.4% | -51.4% | -75.7% | -99.8% | +499,457.4% | +15.4% | -59.9% | |
| – | -118.9% | – | -140.0% | -90.2% | +3.9% | – | +554.1% | -115.0% | -94.7% | – | -308.4% | |
| – | -130.1% | – | -175.6% | +17.1% | -38.7% | – | +651.9% | -113.3% | -42.3% | – | -4,357.1% | |
| – | +541.1% | -304.4% | – | -480.7% | – | +28.3% | -210.9% | – | +115.4% | +45.1% | -212.6% | |
| – | +197.4% | -17.5% | +41.6% | +15.2% | -11.0% | -12.4% | +40.9% | +5.6% | +38.0% | +26.2% | -15.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.